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Abstract Arginase exists in two isoforms. Liver-type arginase ciency [24]. Recently, arginase activity as well as nitric oxide 
(arginase I) is expressed almost exclusively in the liver and synthase (NOS) activity was found to be induced in murine 
catalyzes the last step of urea synthesis, whereas the nonhepatic macrophage-like RAW 264.7 cells by bacterial lipopolysac- 
type (arginase II)is expressed in extrahepatic tissues. Arginase charide (LPS) and the induced arginase was shown to be 
II has been proposed to play a role in down-regulation of nitric arginase II by immunochemical analysis [25]. These results 
oxide synthesis. A cDNA for human arginase II was isolated. A suggest that arginase II plays a role in down-regulation of 
polypeptide of 354 amino acid residues including the putative NO synthesis by decreasing the arginine availability for the 
NH2-terminal presequence for mitochondrial import was pre- NOS reaction. Three different forms of nonhepatic arginase 
dicted. It was 59% identical with arginase I. The arginase II cDNAs from Xenopus laevis were cloned [26]. 
precursor synthesized in vitro was imported into isolated We report here the cloning of a full-length cDNA for hu- 
mitochondria and proteolytically processed, mRNA for human 
arginase II was present in the kidney and other tissues, but was man arginase II and a partial cDNA for the rat enzyme. The 
not detected in the liver. Arginas¢ II mRNA was coinduced with human enzyme contains 354 amino acid residues including the 
nitric oxide synthase mRNA in routine macrophage-like RAW putative NH2-terminal mitochondria-targeting presequence. 
264.7 cells by lipopolysaccharide. This induction was enhanced Mitochondrial import of the arginase II precursor synthesized 
by dexamethasone and dibutyryl cAMP, and was prevented by in vitro with concomitant proteolytic processing was shown. 
interferon-y. Possible roles of arginase II in NO synthesis are Induction of mRNAs for arginase II and inducible form of 
discussed. NOS (iNOS or NOS2) by LPS and other compounds in RAW 
264.7 cells was also reported. 
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2.1. Cloning of human and rat arginase H cDNAs 
1. Introduction A partial cDNA for a candidate human arginase II corresponding 
to nucleotides 18-541 of the human arginase isolog reported in the 
TIGR database, was isolated by reverse transcription-polymerase 
Arginase catalyzes hydrolysis of arginine to urea and or- chain reaction (RT-PCR) using HepG2 mRNA. A full-length 
nithine. Liver-type arginase (arginase I) is expressed almost cDNA was isolated by screening a HepG2 cDNA-~ZAP library (Stra- 
exclusively in the cytosol of the liver of ureotelic animals tagene, La Jolla, CA, USA) using the PCR product as a probe. The 
[1,2] and catalyzes the last step of urea synthesis. The enzyme obtained cDNA was linker attached and inserted into BamHI site of 
the plasmid pGEM-3Zf(+) (Promega, Madison, WI, USA), yielding 
is markedly induced in the perinatal period in coordination pGEM-hAII. To obtain a mammalian expression plasmid, the plas- 
with other urea cycle enzymes [3,4]. Arginase I and the other mid pCAGGS [27] was cut with EcoRI, and arginase II cDNA was 
urea cycle enzymes are regulated by dietary protein [5,6] and inserted after linker attachment, yielding pCAGGS-hAII. A partial 
hormones uch as glucagon and glucocorticoids [7-9]. cDNA rat arginase II cDNA clone was isolated by PCR using mRNA 
clones were isolated from the rat [10,11] and human [12,13] from the small intestine of a male Wistar rat. PCR was carried out 
using the human arginase II primers corresponding to nucleotides 
liver, and the structures of the rat [14] and human [15] genes 294-541. The obtained product was inserted into HincII site of 
were determined. Promoter [16-18] and enhancer [17] regions pGEM-3Zf(+), yielding pGEM-rAII-1. 
were analyzed (reviewed in [19]). 
An isoform of arginase (arginase II) that differs from argi- 2.2. In vitro translation and mitochondrial import 
mRNA for human arginase II was synthesized byin vitro transcrip- 
nase I in catalytic, molecular and immunological properties i tion of plasmid pGEM-hAII using SP6 RNA polymerase. The proce- 
present in nonhepatic tissues such as kidney, small intestine dures of in vitro translation and the import into isolated rat liver 
and lactating mammary gland [20-23]. Arginase II appears to mitochondria were described previously [28]. 
be located in the mitochondria [23]. Arginase II activity in the 
2.3. Cell culture and DNA transfection kidney is markedly elevated in patients with arginase I deft- Monkey kidney COS-7 cells and mouse macrophage-like RAW 
264.7 cells were grown in 10-cm dishes in Dulbecco's modified Eagle's 
*Corresponding author. Fax: (81)(96)373-5145. medium and Eagle's minimal essential medium, respectively, each 
E-mail: masa@gpo.kumamoto-u.ac.jp supplemented with 10% fetal calf serum. Transfection to COS-7 cells 
was carried out using TransIT-LT1 Polyamine (PanVera Corp., Ma- 
Abbreviations." LPS, lipopolysaccharide; NO, nitric oxide; NOS, nitric dison, WI, USA) according to the protocol supplied by the manufac- 
oxide synthase; iNOS or NOS2, inducible isoform of NOS; OTC, turer with 15 lag of the expression plasmid. After transfection, cells 
ornithine transcarbamylase; PCR, polymerase chain reaction were cultured for 36 h prior to harvesting. 
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2.4. RNA blot analysis 30% 3 6 9 12 (min)  
RNA extraction, agarose gel electrophoresis and membrane transfer 
were performed as described previously [29]. Hybridization was per- - -I- + PK 
formed using as probes random-primed 32p-labeled human arginase I1 A I I  + TX-100  
eDNA or human [~-actin eDNA, or digoxigenin-labeled antisense 
RNAs for rat arginase II or rat iNOS.enzyme.The antisense RNAs were L ~  .......... 
synthesized using as templates pGEM-rAII-1 or pcDNAII-riNOS 40 k 
. . . .  m [29] cut by an appropriate restriction The radioactive bands 
were visualized by autoradiography on X-ray films. Chemilumines- 
cence signals derived from hybridized probes were detected on X- 
ray films using a DIG luminescence detection kit (Boehringer Mann- OTC 
heim, Germany). 
k ................................................................. .. .. .. .......... . . . . .  p 2.5. Measurement of arginase activity 40 
Cultured cells and rat liver were homogenized in 20 mM HEPES- - -m 
KOH (pH 7.5) containing 1% Triton X-100, 20% glycerol and 1 mM 
dithiothreitol. After centrifugation, the supernatants were used for 
measurement of arginase activity [5]. Fig. 2. In vitro import of human arginase II precursor (All) and 
human OTC precursor (OTC) into isolated mitochondria. The 3ss- 
labeled precursor proteins synthesized in rabbit reticulocyte lysate 
3. Results and discussion were incubated with rat liver mitochondria (100 p.g of protein) at 
25°C for the indicated times. The mitochondria were reisolated and 
subjected to SDS-PAGE and fluorography. Where indicated, the 
3.1. Cloning of human arginase 11 eDNA isolated mitochondria were treated with 20 Ixg/ml of proteinase K
A partial eDNA sequence (THC124562-1) that is a candi- (PK) with or without 0.1% Triton X-100 (TX-100) for 15 rain on 
date for arginase II was reported in the T IGR human eDNA ice prior to SDS-PAGE. 30%, 30% of input precursors, p, precursor 
database. This eDNA of 664 bp contained the protein coding form; m, mature form. 40 k, position of the OTC precursor. 
sequence corresponding the NH2-terminal two-thirds of the 
suggested entire sequence of arginase 1I. A full length 
eDNA was isolated by combination of PCR cloning and viewed in [30]). The putative human arginase II precursor was 
screening of a HepG2 eDNA library. The eDNA contained 73% identical with nonhepatic form (probably also the pre- 
the 5'-untranslated sequence of 20 bp, protein coding se- cursor form, xArgl in [26]) of X. laevis arginase. 
quence of 1062 bp (354 amino acid residues), 3'-untranslated 
sequence of 272 bp and a poly(A) tract (the sequence is de- 3.2. Expression of arginase H in COS-7 cells 
posited in the DDBJ/EMBL/GenBank nucleotide sequence eDNA for the putative arginase II precursor was subcloned 
databases with the accession umber D86724). into a potent mammalian expression vector pCAGGS and 
Fig. 1 shows a sequence comparison of the putative human was transfected into COS-7 cells. In RNA blot analysis, ex- 
arginase II with human arginase I and X. laevis nonhepatic pression of a hybridized RNA was observed in the transfected 
arginase. The predicted molecular weight of the putative argi- cells. Arginase activity was not detectable in control cells, 
nase I1 is 38 577. This polypeptide was 59% identical with whereas a high enzyme activity (2.1 I.tmol/min/mg protein) 
arginase I and had additional NH2-terminal sequence of was detected in the transfected cells. This value was compar- 
about 18 residues. This extrapeptide portion contained three able to that of arginase I in rat liver that was measured si- 
arginine residues and no acidic residue, and appeared to be multaneously. 
the presequence for mitochondrial targeting and import (re- 
3.3. Import of the arginase H precursor into isolated 
mitochondria 
hA~ ~.. m~x-sm~x~r, . . . . . .  ~  . . . .  The putative arginase II precursor and as a positive control, 
xA1 l : ~ ~ x ~ c s ~ A ~ r ~ ¢ ~ . ~ , ~ ' ~  ornithine transcarbamylase (OTC) precursor [28] were synthe- 
sized in rabbit reticulocyte lysate and subjected to mitochon- hAl 38 : ~ y ~ .  ~PFADI~N~, SPFQ-  ~ .~.  ~ . A ~  ,GRI SLV 
hail 56:I~S.I.GCIllI~FGI)LS'Fl'~r~I~D/.YIx~x~I'¢I~,,, *,* *.*** * ** * *** ** **** *.* . . .  ,,rav~sew,, , ,,, drial import assay. The arginase II precursor synthesized in 
xA1 61 : ~ G D L I ~ g S ~ E L Y N S I V K H P R T V ~ S K A V G A G H T C V T  
vitro migrated in SDS-PAGE as a polypeptide of about 40 
hAl 97 : ~ H S  LAIGS I S~*~VHPDLGVIWVDAHTD INTP LTTT S GNLHGQPVSFLLEXI/(GKI 
hAll 116:I,G~IlSL~GTIS~qltCPDLCVVW~AF.AD~N'~LTTS$~.G~***S.~,I~,~ . . . .  kDa (Fig. 2). This value was close to that predicted from the 
~A1 ~21:~&~,~¢~~t~t~l .~. .a~.~4s~ amino acid sequence. When the putative precursor was incu- 
hAI 157:PD%W=Slr~I~.~JkI~I ,,I~,I**G~***VD, P .G~. I**LKTLGIKYFS~DRLGI **G~** TL~; ;2~ ~ bated with isolated rat liver mitochondria, it was imported 
hAi l  176 : pQLP~SWIE~CI  S SAS IVYI GLRDVDPPEHFI  LKNYD IQ~S~D 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  into the organelle with concomitant processing to the mature xA1 181 : pp I~G~ SI~%E~ CLS/t~DIVYI GLRDI2~AEQFI  LENYD ISYYSR~HI DC24GIKKVM~WI~ 
form of about 38 kDa in a time-dependent manner. Import 
hAl 217 : S ~  IHLSFDVDGLDP SFTPATGTPVVGGLT~REGLY ITEE I  YKTGLLSGLDIM • * ******** * ** ****************  ** *** ***** ** 
hAll 236:DIJ, G~RPIItI~"DII~FI~*r-.~I~A:T~LTTREGt~-T-lUmIII~'~'GIJ,-~t,PbY across the mitochondrial membranes was verified by the pro- 
xA1 241:DQIJ~GI~P~BPIHLSFDIDAFDPALAP~GGLI"/~gGVXI~IIII~ZG~LSAVDLV teinase K digestion experiments. About 55% of the added 
hA] 277 :E~F~S AVAITLACFGLARE~-KP  - - - ID¥~PK . . . . . . . . . . . . . . . . . . . .  precursor was imported into the mitochondria. The import hAll 296 : ~QLATSEEEAKTTANLA~ SFGQTREGGH .. . .  IV~LPTP  S SPDES~%~AR • *** ** ** * ***********  *******  * * ***** ** * 
xA~ ao l :~n.~,s~,~~r~=wwsrs=~o and processing pattern resembled that for the OTC precursor. 
hA[I 352:~ These results show that arginase II is initially synthesized as a 
xA~ ~l..w larger precursor of about 40 kDa with the NH2-terminal pre- 
Fig. 1. Predicted amino acid sequence of putative human arginase II sequence, imported into the mitochondria nd processed to 
precursor (hAil) and comparison with those of human arginase I the mature form of about 38 kDa. We speculate that cleavage 
(hA1) and of X. laevis nonhepatic arginase (xA1, xArgl in [26]). 
Gaps were introduced to increase the homology and identical amino occurs between Ser-22 and Val-23 (Fig. 1) because a basic 
acids are shown by asterisks. The triangle indicates the putative residue dominates at position -2  or positions -2  and -3  
cleavage site. among many precursor proteins [30]. 
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Fig. 3. RNA blot analysis for arginase II in human tissues. The filter with human tissue poly (A) + RNAs (Clontech, Palo Alto, CA, USA) was 
hybridized using as probes 32P-labeled DNA for human arginase II (A) or human ~-actin (B). Lane 1, heart; lane 2, brain; lane 3, placenta; 
lane 4, lung; lane 5, liver; lane 6, skeletal muscle; lane 7, kidney; lane 8, pancreas. Molecular markers (Clontech) are shown on the left. 
3.4. Expression ofarginase H mRNA in human tissues vented by interferon-•. The effects of LPS and interferon-T on 
RNAs from human tissues were subjected to RNA blot the mRNAs agree with the report [25] on effects of these 
analysis. Arginase II mRNA of about 1.8 kb was detected compounds on iNOS and arginase II activities. When 10 ~g/ 
in various tissues (Fig. 3). The mRNA was expressed most ml LPS was used, induction of iNOS mRNA was similar to 
strongly in the kidney, much less strongly in the brain, skeletal that with 100 ~g/ml LPS, whereas induction of arginase II 
muscle, placenta nd lung in this order, but apparently not in mRNA was much less evident (data not shown). Induction 
the liver, heart and pancreas. The high mRNA in the kid- of arginase I mRNA was not observed under these conditions 
ney is in accord with a high arginase II activity in rat kidney (data not shown). 
[22]. It was proposed that arginase II plays a role in down-reg- 
ulation of NO synthesis by decreasing the availability of argi- 
3.5. Coinduction o fmRNAsfor  arginase H and iNOS in nine for the NOS reaction [25]. Both iNOS and arginase II 
LPS-activated RAW 264. 7 cells and effects of were induced by LPS, but the effects of interferon-~ and 
dexamethasone, cAMP and interferon- 7 cAMP differed between the two enzymes. Interferon- 7 may 
Wang et al. [25] reported that activities of arginase and stimulate NO synthesis by suppressing arginase II induction 
NOS are coinduced RAW 264.7 cells by LPS. The induced as well as by inducing iNOS. On the other hand, dexametha- 
arginase was shown to be arginase II by immunoprecipitation sone and cAMP may suppress NO synthesis by inducing ar- 
experiments. We examined whether the increased arginase ac- ginase II. This may partly explain the therapeutic effects of 
tivity is due to induction of its mRNA. A partial rat cDNA dexamethasone and catecholamines in the shock treatment. 
(the sequence is deposited in the DDBJIEMBL/GenBank nu- Common and discrete steps in signal transduction and gene 
cleotide sequence databases with the accession number cascades appear to be involved in regulation of these two 
D86928) obtained by PCR was used as a probe. When genes. The cDNAs for arginase II will provide an important 
RAW 264.7 cells were treated with 100 p~g/ml LPS for 24 h, tool for the studies on regulation of the enzyme gene and its 
iNOS mRNA was markedly induced (Fig. 4). This induction role in NO synthesis. 
of iNOS mRNA by LPS appeared to be somewhat enhanced 
by dexamethasone and interferon- 7, but was little affected by 
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